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ABSTRACT
Background: The incidence of heart failure in diabetic subjects is high even in the absence of hypertension 
and coronary artery disease. Aims: The purpose of this study was to study the incidence of diastolic 
dysfunction in diabetic subjects and its relation to age, duration of diabetes mellitus (DM), Glycosylated 
hemoglobin (HbA1c) levels, obesity indices and diabetic microangiopathies. Settings and Design: This 
was a case control prospective study conducted at the teaching hospital during a one year period. Materials 
and Methods: A total of 127 subjects (case) with type 2 diabetes of more than five years duration were 
studied. Total 100 healthy subjects were included as the control group. Echocardiography was performed to 
assess left ventricular diastolic function. Results: Out of the total 127 subjects, 69 (54.33%) from the case 
group had diastolic dysfunction, and 11% amongst 100 in the control group population showed the diastolic 
dysfunction (P < 0.001). Patients with a longer duration of DM (of 11 to 15 years) had a higher prevalence 
of diastolic dysfunction (P < 0.02). Subjects with high waist circumference and high waist to hip ratio had 
statistically significant diastolic dysfunction with ‘P’ =0.001 and ‘P’ = < 0.02 respectively. Subjects with 
HbA1c > 7.5% had a higher prevalence of diastolic dysfunction than subjects with HbA1c < 7.5% (P < 0.02). 
Diastolic dysfunction was present in majority of the subjects with autonomic neuropathy and retinopathy. 
Conclusions: Present study reveals high incidence of diastolic dysfunction in asymptomatic diabetic; subjects 
and, this finding was correlated with the duration of diabetes, HbA1c levels, obesity indices and diabetic 
microangiopathies. We conclude that early diagnosis and institution of treatment will reduce morbidity and 
improve the outcomes, and prevent future heart failure.
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diabetic heart disease as a distinct clinical entity. Diastolic 
heart failure (HF) is also referred to as HF, with preserved 
left ventricular systolic function. Many studies have reported 
that the incidence of heart failure in diabetic subjects is 
high even in the absence of hypertension and coronary 
artery disease. Studies have reported a high prevalence 
of pre-clinical diastolic dysfunction among subjects with 
DM.[1] The evidence indicates that myocardial damage in 
diabetic subjects affects diastolic function before the systolic 
function. The pathogenesis of this left ventricular (LV) 
dysfunction in diabetic subjects is not clearly understood. 
Diabetic cardiomyopathy has been proposed as an 
independent cardiovascular disease, and many mechanisms, 
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INTRODUCTION
The incidence of diabetes mellitus (DM) is increasing 
worldwide and rapidly assuming epidemic proportions. 
Over the last three decades, a number of epidemiological, 
clinical and autopsy studies have proposed the presence of 214 Journal of Cardiovascular Disease Research Vol. 2 / No 4
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such as microvascular disease, autonomic dysfunction, 
metabolic disorders, and interstitial fibrosis, have been 
suggested as causative factors.[2] However, the exact   
etio-pathogenesis of diabetic cardiomyopathy still   
remains unclear. So far, very few population-based 
studies have been carried out in India, to demonstrate the 
prevalence of diastolic dysfunction in diabetic subjects 
in the Indian patients. The objective of our study was   
to determine whether there is any association between 
diastolic dysfunction and type 2DM, even in the 
asymptomatic subjects. Thus, this prospective case control 
study was conducted with the aim of determining the 
prevalence of asymptomatic LV diastolic dysfunction in 
type 2 diabetes subjects, and its relation to age, duration 
of DM, HbA1c, obesity indices and other diabetic 
complications such as microangiopathies.
MATERIALS AND METHODS
The objectives of our study
•  To determine the incidence of LV diastolic dysfunction 
in asymptomatic type 2 DM patients and to compare 
it with normal subjects; 
•  and, to quantify the relation of LV diastolic 
dysfunction with age, duration of DM, HbA1c, 
obesity indices and other diabetic complications such 
as microangiopathies.
For the study, we hypothesized that the diastolic 
dysfunction, [as assessed by the mitral peak velocity of 
early filling (E) to early diastolic mitral annular velocity (e’) 
(E/e’) ratio], worsens with age, duration of DM, HbA1c 
and obesity indices. A total of 127 normotensive subjects 
(case), with type 2 DM of more than five years duration 
with no clinical evidence of cardiac disease were studied. 
A total 100 apparently healthy subjects with age and sex 
matched were included as the control group. This case-
control study was designed to determine the prevalence of 
asymptomatic left ventricular diastolic dysfunction in type 
2 DM subjects and its relation to patient’s age, duration of 
DM, control of diabetes as determined by HbA1c levels, 
biochemical profile and obesity indices. This was a case 
-control prospective, observational study conducted out at 
the Krishna Institute of Medical Sciences, Karad, over a 
period of one year period from January 2009 to December 
2009. This study was approved by the ethical committee of 
Krishna Institute of Medical Sciences University Karad.
Inclusion criteria for case population 
All type 2 DM with patients with duration > 5 years with 
normal left ventricular systolic function (LVEF: ≥ 50%). 
Exclusion criteria for case population
•  Subjects with evidence of coronary artery disease 
- CAD [excluded by history of angina, chest pain, 
Electrocardiogram (ECG) changes and abnormal 
Treadmill test (TMT) results];
•  subjects with evidence of valvular disease; 
•  hypertensive patients, antihypertensive agents and/
or angiotensin-converting enzyme (ACE) inhibitors, 
with evidence of left ventricular hypertrophy   
on echocardiography; 
•  and, subjects with poor transthoracic echo window.
Detailed medical history was collected from each eligible 
subject; and, they underwent physical examination and 
biochemical investigations. After a 12-hour fast, a venous 
blood sample was collected and sent to the biochemistry 
laboratory for estimation of the following: plasma glucose 
level; glycatedHbA1c; total serum cholesterol (TC); 
High-density lipoprotein (HDL) cholesterol; Low density 
lipoprotein (LDL) cholesterol; Very low density lipoprotein 
(VLDL); and, serum triglyceride levels (TG). ECG 
was done in all subjects. Physical examination included 
routine general examination, systemic examination and 
anthropometric evaluation including height (meter), hip 
circumference in centimetre (HC), waist circumference in 
centimetre (WC) and weight in kilogram.
Echocardiography
All the subjects were underwent resting transthoracic 
2-dimensional echocardiography and Doppler 
imaging, to assess left ventricular diastolic function. 
Echocardiographer was not aware of this study 
to avoid bias in the interpretation. A transthoracic 
2-dimentionsional echocardiogram (TTE) with pulsed 
Doppler evaluation of transmitral inflow and Tissue 
Doppler Imaging (TDI) and 2D echocardiography 
was performed to minimize the errors in assessing the 
diastolic dysfunction. Echocardiography was performed 
by harmonic imaging mode by Acuson-Siemens-X 300 
echocardiography machine (5-1 MHz multi-frequency 
probe) according to the standard protocol. Pulsed-wave 
Doppler (PWD)-derived transmitral inflow velocities 
was obtained in the apical 4-chamber view, with the 
sample volume placed at the mitral valve leaflet tips.[3] 
Measurements included the transmitral early diastolic 
rapid filling (E-wave) and atrial contraction late filling 
(A-wave) velocities to calculate E/A ratio, isovolumteric 
relaxation time (IVRT) and deceleration time (DT). 
For tissue Doppler imaging, the mitral annulus velocity 
was obtained with a 2 mm sample volume placed at the 215 Journal of Cardiovascular Disease Research Vol. 2 / No 4
Patil, et al.: Diastolic dysfunction in type 2 diabetes mellitus with normal LVEF
lateral side and septal side of the mitral annulus. Diastolic 
dysfunction was labelled according to the standard 
guidelines. Left ventricular overall ejection fraction 
(systolic function) was calculated by modified Simpson’s 
method; and, LVEF ≥ 50% was considered as normal.[3,4] 
All echocardiographic measurements were averaged over 
three consecutive cardiac cycles, measured by a single 
investigator blinded to all other variables [Figure 1].
Diagnostic criteria
•  Dyslipidemia: was defined if TC ≥ 200 mg/dL; LDL 
cholesterol ≥ 130 mg/dL; HDL cholesterol 40 mg/
dL; and, TG ≥ 150 mg/dL.[5] 
•  Obesity indices: Cut-off for high Body Mass Index 
(BMI) was ≥ 25 for females and ≥ 27 for males. Cut-
off for high waist to hip ratio (WHR) was ≥ 0.9 for 
males, and ≥ 0.8 for females. Cut-off for high WC was 
> 85 cm for females and > 90 cm for males.[6]
•  Diabetes mellitus (DM): If a subject is a known 
diabetic on treatment, or with any fasting blood sugar 
level (F-BSL) ≥ 126 mg/dL.[6] 
•  Retinopathy: Microangiopathy was assessed 
by fundoscopy (direct ophthalmoscopy). The 
ophthalmologist doing fundoscopy was unaware of 
this study. Fundoscopic examination was done after 
dilating the pupil with tropicamide (1%). Retinopathy 
status was labeled as follow:
•  no evidence of diabetic retinopathy;
•  background diabetic retinopathy, defined as 
presence of one or more microaneurysms, 
punctate or striate intraretinal hemorrhages, and 
hard exudates;
•  preproliferative diabetic retinopathy defined as 
soft exudates, venous beading, and intraretinal 
microvascular abnormalities;
•  proliferative diabetic retinopathy characterized by 
neovascularization on or within one disk diameter 
of the disk in extent. After these initial evaluations 
were completed, 127 diabetic subjects were enrolled 
into the study protocol. Hundred apparently 
healthy individuals, matched for age and sex served 
as control group.[7]
•  Autonomic neuropathy: Autonomic function 
was evaluated by unmasking the sympathetic 
dysfunction by the blood pressure (BP) response 
to standing. A fall in systolic BP on erect position 
of < 10 mmHg was defined as normal and > 30 
mmHg as abnormal.[7]
•  Diastolic dysfunction: LV diastolic dysfunction was 
considered to be present if any of the following 
findings were seen, as previously described:[3,4]
•  E/A ratio < 1 or > 2
•  DT < 150 or > 220 ms, 
•  IVRT < 60 or > 100 ms, or
•  E/e’ ratio > 15
Figure 1: Two dimensional transthoracic echocardiographic evaluation of diastolic dysfunction by pulse wave Doppler (PW) at mitral valve, 
velocity propagation (VP) by colour ‘M’ mode and tissue Doppler imaging (TDI) at septal and lateral mitral annulus216 Journal of Cardiovascular Disease Research Vol. 2 / No 4
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Statistical analysis
Data was analysed for mean, percentage, standard 
deviation, chi square test, multiple correlation and 
multivariate analysis, by using SPSS-10 (Statistical Package 
for the Social Sciences) for Windows (SPSS, Chicago, 
IL). Variables that were not normally distributed were 
reciprocally transformed for analysis. The‘t’-test and 
Chi-Square tests were applied to study quantitative 
and qualitative data, respectively with ‘P’ value < 0.05 
was considered statistically significant. Correlation of 
various factors was determined using r2 and multiple 
linear regression analysis. Correlation (r) findings 
were describes as follows: r = 0.8 (high correlation 
coefficient); r = 0.4–0.7 (moderate correlation); and,   
r = 0.3 and above (low correlation coefficient). 
RESULTS
A total 127 subjects with type-2 diabetes mellitus (cases) 
and 100 healthy age and sex matched controls were 
included in this case-control prospective study. Out of 
127 subjects with type -2 DM, 69 (54.93 %) were male 
and 58 (46.66%) were female. Total 56 (54%) male and 
44 (46%) female were control healthy subjects. Mean 
standard deviation of biochemical, anthropometric 
indices and echocardiographic parameters were 
obtained [Table 1]. Mean of BMI in the case group 
was significantly higher as compared to the control 
group (‘P’ < 0.05). Mean of WC in the case group was 
significantly higher as compared to the control group 
(‘P’ = 0.02). Mean of WHR in the case group was 
significantly higher as compared to the control group (‘P’ 
< 0.02). Mean of TC in case group was high compared 
to control group. Mean of TG in the case group was 
significantly higher as compared to control group   
(‘P’ =0.032). Mean of LDL- cholesterol in the case group 
was higher as compared to the control group. Mean of 
HDL- cholesterol in the case group was significantly 
lower as compared to the control group (‘P’ < 0.05). 
Mean of BSL in  the case group was significantly higher 
as compared to the control group (‘P’ = 0.01). Mean 
of E/A ratio in the case group was significantly lower 
as compared to the control group (‘P’ = 0.02). Mean 
of E/e’ ratio in the case group was significantly higher 
as compared to the control group (‘P’ < 0.001). Total 
69 (54.33%) subjects from the case group had diastolic 
dysfunction; and, 11 (11%) amongst control group had 
the diastolic dysfunction. Diastolic dysfunction in type 
-2 DM subjects was significantly higher as compared to 
the control group (‘P’ < 0.001) with odds ratio of 2.18 
[Table 1].
Relation of diastolic dysfunction with various 
dependent variables in type 2 diabetes subjects
Out of 89 subjects with HbA1c < 7.5%, 39 (42.82%) 
had diastolic dysfunction; and, out of 38 subjects with 
HbA1c > 7.5%, 31 (81.57%) had diastolic dysfunction. 
Subjects with HBA1c > 7.5% had more prevalence of 
Table 1: Mean and standard deviation of numerical parameters of the patients in the study
Variables Case population Control population ‘P’ value
Male 
(n=69)
Female 
(n=58)
Male 
(n=56)
Female 
(n=44)
Age (years) 51 ± 9 49 ± 10 ± 49 ± 7 48 ± 8 NS
Duration of diabetes (years) 11 ± 5 10 ± 4 - - -
Body mass index (Kg/m2) 27.6 ± 2.2 26 ± 2.5 23.5 ± 1.6 23.7 ± 1.3 < 0.05
Waist circumference (WC - cm) 92 ± 8 78 ± 7 77 ± 3.9 74 ± 6 0.02
Waist to hip ratio (WHR) 0.92 ± 0.17 0.84 ± 0.19 0.75 ± 0.19 0.75 ± 0.15 < 0.02
Total cholesterol 213 ± 24.4 223 ± 25 147 ± 8.7 135 ± 15 NS
Triglyceride 208 ± 25.7 198 ± 23.5 135 ± 7.9 129 ± 9 0.032
LDL- cholesterol 134 ± 13 145 ± 10 96 ± 13 106 ± 7.8 NS
HDL- cholesterol 39 ± 16 38.5 ± 13 49.5 ± 7.8 43 ± 5.7 < 0.05
Blood sugar level 145 ± 16.7 139 ± 23.5 85 ± 7.8 85 ± 5.0 0.01
HbA1c (%) 8.3 ± 1.91 8.1 ± 1.3 - - -
E/A ratio (PW) 0.79 ± 0.13 0.81 ± 0.11 1.21 ± 0.22 1.19 ± 0.11 0.02
E/e' ratio (TDI) 18.6 ± 3.5 18.3 ± 3.2 8.8 ± 1.24 8.67 ± 2.16 < 0.001
IVRT (ms) 79 ± 9 81 ± 7 95 ± 14.8 97 ± 16 NS
DT (ms) 168 ± 23 172 ± 19 159 ± 23.8 139 ± 11 < 0.002
EF (%) 54 ± 3 55 ± 2 62 ± 3 49 ± 3 NS
Diastolic dysfunction 39 (56.52%) 30 (51.72%) 6 (10.71%) 5 (11.36%) < 0.001
LDL = Low density lipoprotein; HDL = High density lipoprotein; HbA1c = glycosylated haemoglobin; E = early diastolic (E-wave: cm/s) velocity; A = atrial (A-wave: cm/s) 
velocity; E/e’ ratio = mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (e’) ratio; IVRT = isovolemetric relaxation time; DT = deceleration time; 
EF = Ejection fraction; PW = Pulse Wave Doppler; TDI = tissue Doppler imaging; NS = not significant217 Journal of Cardiovascular Disease Research Vol. 2 / No 4
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diastolic dysfunction, than subjects with HBA1c < 7.5%   
(‘P’ < 0.02). Out of 23 subjects with age < 45 years, 
10 (43.47%) had diastolic dysfunction; and, out of 104 
subjects with age > 45 years, 61 (58.65%) had diastolic 
dysfunction. Diastolic dysfunction was significantly high 
in patients with age > 45 years, compared to age < 45 
years (‘P’ < 0.05). Total 78 (61.41%) subjects were with 
the duration of diabetes between 6-10 years, and 49 
(38.58%) were between 11-15 years. Out of 78 (61.41%) 
subjects with duration of diabetes between 6-10 years, 32 
(41.02%) had diastolic dysfunction. Out of 49 (38.58%) 
subjects with duration of diabetes between 11-15 years, 37 
(75.51%) had diastolic dysfunction. Comparing duration 
of diabetes of 6 to 10 years and 11 to 15 years with 
diastolic dysfunction, patients with 11 to 15 years duration 
of diabetes had more prevalence of diastolic dysfunction 
(‘P’ < 0.02). Total 27 (21.25%) subjects had retinopathy, of 
which 24 (88.88%) had diastolic dysfunction (‘P’ < 0.002). 
Out of 32 (25.19%) subjects with postural hypotension, 
27 (84.37%) had diastolic dysfunction (‘P’ = 0.001)   
[Table 2 and Figure 2].
Relation of diastolic dysfunction with obesity indices
Total 23 (33.33%) male and 13 (24.41%) female patients 
had high BMI; and, out of them 16 (69.56%) male and 
8 (61.53%) female had diastolic dysfunction. Total 32 
(46.37%) male and 29 (50%) female patients had high 
WC; and, out of them, 25 (78.12%) male and 21 (72.41%) 
female patients had diastolic dysfunction (‘P’ =0.001). 
Total 28 (40.57%) male and 27 (46.55%) female patients 
had high WHR; and, out of them, 22 (78.57%) male 
and 19 (81.48%) female had diastolic dysfunction (‘P’ 
= < 0.02). Subjects with high WC and high WHR had 
statistically significant diastolic dysfunction [Table 3 and 
Figure 3].
Figure 3: Relation of diastolic dysfunction with obesity indices in type 2 DM
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Figure 4: Correlation of parameters of diastolic dysfunction with biochemical profile and obesity indices  in type 2 DM
Table 2: Relation of diastolic dysfunction with various dependent variables in type 2 diabetes mellitus subjects in 
the study
Variables Diastolic dysfunction  
present
Diastolic dysfunction 
absent
Total (%) ‘P’ value
HBA1c (< 7.5%) (n = 89) 39 (42.82) 50 70.07 < 0.02
HBA1c (> 7.5%) (n = 38) 31 (81.57) 7 29.92
Age < 45 years (n = 23) 10 (43.47) 13 18.11 < 0.05
Age > 45 years (n = 104) 61 (58.65) 43 81.88
Duration of diabetes mellitus
6-10 years (n = 78)
32 (41.02) 46 61.41 < 0.002
Duration of diabetes mellitus
11- 15 years (n = 49)
37 (75.51) 12 38.58
Retinopathy present (n = 27) 24 (88.88) 3 21.25 < 0.002
Autonomic neuropathy (postural 
hypotension) (n = 32)
27 (84.37) 5 25.19 < 0.001
Where, HbA1c = glycosylated haemoglobin, Figures given in parenthesis are in percentage
Table 3: Relation of diastolic dysfunction with obesity indices of the patients in the study
Obesity indices Male (n = 69) Female (n = 58) Diastolic dysfunction present  ‘P’ value
Male Female
Body mass index (Kg/m2) 23 (33.33) 13 (24.41) 16 (69.56) 8 (61.53) NS
Waist circumference (cm) 32 (46.37) 29 (50) 25 (78.12) 21 (72.41) < 0.001
Waist to hip ratio 28 (40.57) 27 (46.55) 22 (78.57) 19 (81.48) < 0.02
NS = not significant, Figures given in parenthesis are in percentage
Correlation of echocardiography parameters of 
diastolic dysfunction with obesity indices, duration 
of diabetes mellitus and biochemical profile 
Age was negatively correlated with E/A ratio (-0.59); 
and, positively with E/e’ ratio (+0.2). WC was negatively 
correlated with E/A ratio (-0.34); and, positively with 
E/e’ ratio (+0.48). WHR was negatively correlated with 
E/A ratio (-0.67); and, positively with E/e’ ratio (+0.22). 
Duration of diabetes was negatively correlated with 
E/A ratio (-0.51); and, positively with E/e’ ratio (+0.64). 
GlycatedHbA1c level was negatively correlated with E/A 
ratio (-0.23); and, positively with E/e’ ratio (+0.12). Fasting 
BSL was negatively correlated with E/A ratio (-0.29); and, 
positively with E/e’ ratio (+0.31). Serum TG level was 
negatively correlated with E/A ratio (-0.28); and, positively 
with E/e’ ratio (+0.08). Serum HDL cholesterol levels 
were negatively correlated with E/e’ ratio (-0.23); and, 
positively with E/A ratio (+0.09) [Table 4 and  Figure 4]. By 
multivariate analysis of covariance (MACOVA) and Cox’s 
proportional hazard regression analysis, (after adjustment 
for age, sex) it was determined that the diastolic dysfunction 
(measured by E/A ratio and E/e’ ratio), was significantly 
associated with longer duration of DM, HbA1c, serum 219 Journal of Cardiovascular Disease Research Vol. 2 / No 4
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TG levels, WC and WHR, retinopathy and autonomic 
neuropathy (‘P’ < 0.002). 
DISCUSSION
Our current findings demonstrate that pre-clinical diastolic 
dysfunction is common in patients with DM. Pre-clinical 
diastolic dysfunction has been broadly defined as diastolic 
dysfunction in patients with normal systolic function, and 
no symptoms of heart failure (HF). Present study reveals 
high burden of diastolic dysfunction in cohort of type 2 
DM population. In the present prospective case control 
study, 127 subjects with type-2 DM as cases; and, 100 
healthy subjects as controls, were included. Overall mean of 
obesity indices like BMI, WC and WHR were significantly 
higher in subjects with type 2 DM compared to the control 
group. Mean of fasting BSL, HbA1c, serum TC, serum TG 
and LDL cholesterol in case group was significantly higher 
as compared to the control group. The mean of HDL 
cholesterol was lower in the case group as compared to the 
control group. Total 69 (54.33%) subjects from the case 
group had diastolic dysfunction, and 11 (11%) amongst 
control group showed the diastolic dysfunction. Diastolic 
dysfunction in type -2 diabetes subjects was significantly 
higher as compared to the control group (‘P’< 0.001). E/A 
ratio negatively correlated with age, WC, WHR, duration of 
DM, HbA1c level, fasting BSL, and serum TG levels; and, 
positively correlated with serum HDL- cholesterol. E/e’ 
ratio positively correlated with age, WC, WHR, duration 
of DM, HbA1c level, fasting BSL, and serum TG levels; 
and, negatively correlated with serum HDL- cholesterol. 
Duration of diabetes mellitus of 11 to 15 years had more 
prevalence of diastolic dysfunction (‘P’ < 0.02). Subjects 
with high WC and high WHR had statistically significant 
diastolic dysfunction. Subjects with HBA1c > 7.5% had 
more prevalence of diastolic dysfunction than subjects 
with HBA1c < 7.5% (‘P’ < 0.02). Diastolic dysfunction was 
significantly high in patient with age > 45 years compared 
to age < 45 years (‘P’ < 0.05). Diastolic dysfunction 
was present in majority of the subjects with autonomic 
neuropathy and retinopathy [Figure 2].
We compared our results with various studies. Soldatos   
et al.[8] in their case control study of 55 individuals with 
type -2 DM found that Diastolic dysfunction, present in 
a significant proportion of  population with Type 2 DM. 
Similarly, in the present study, 54.33% of subjects from 
the case group had diastolic dysfunction and 11 (11%) 
amongst control group had the diastolic dysfunction (P < 
0.001). Sacre et al.[9] found that there was an independent 
association between global cardiac autonomic neuropathy 
(CAN) and left ventricular (LV) dysfunction in patients 
with type 2 DM. These findings are comparable to our 
study, where diastolic dysfunction was present in majority 
of the subjects with autonomic neuropathy documented by 
postural hypotension. Out of the 32 (25.19%) subjects with 
postural hypotension; 27 (84.37%) had diastolic dysfunction 
(‘P’= 0.001). Van Heerebeek et al.[10] in their study of 36 
type -2 DM patients stated that, the cardiomyocyte resting 
tension is more important when LVEF is normal. Excessive 
diastolic left ventricular stiffness is an important contributor 
to heart failure in subjects with DM. Diabetes is presumed 
to increase stiffness through myocardial deposition of 
collagen and advanced glycation end products. Similarly, in 
the present study, 54.33% of subjects from the case group 
had diastolic dysfunction with normal LVEF.
Masugata et al.[11] in their case control study of 77 
normotensive patients found that, the cardiac diastolic 
dysfunction without LV systolic dysfunction in patients 
with well-controlled type 2 DM is related neither to 
hypertension nor LV hypertrophy, but rather to aging 
and the duration of type 2 DM. Similarly, in the present 
study, total 54.33% of subjects from case group without 
hypertension and CAD had diastolic dysfunction with 
normal LV systolic function. Annonu et al.[12] in their case 
control study of 66 subjects found that there was an inverse 
correlation between the duration of diabetes and E/A 
ratio (r = -0.4, ‘P’ <.005). E/A ratio < 1 was associated 
with a higher prevalence of retinopathy (49% versus 
20%, ‘P’ =0.01) and abnormal blood pressure response 
to standing (29% versus 4%, ‘P’ <.005). LV systolic and 
diastolic abnormalities are correlated with the duration 
of diabetes and with other diabetic microangiopathies, 
such as diabetic retinopathy and neuropathy. These results 
are comparable to the present study, where diastolic 
dysfunction was present in majority of the subjects with 
autonomic neuropathy and retinopathy with ‘P’ = 0.001 and 
Table 4: Correlation of parameters of diastolic 
dysfunction with biochemical profile and obesity 
indices of the patients in the study
Variables Echocardiographic 
parameters of diastolic 
dysfunction
E/A ratio E/e’
Age -0.59 +0.20
Waist circumference -0.34 +0.48
Waist to hip ratio -0.67 +0.22
Duration of diabetes mellitus -0.51 +0.64
Glycosylated hemoglobin (HbA1c) -0.23 +0.12
Fasting blood sugar level -0.29 +0.31
Serum triglyceride level -0.28 +0.08
HDL cholesterol +0.09 -0.23
HDL = High density lipoprotein220 Journal of Cardiovascular Disease Research Vol. 2 / No 4
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0.002, respectively. Duration of diabetes mellitus of 11 to 
15 years had more prevalence of diastolic dysfunction as 
compared to the 6 -10 years group (‘P’ < 0.02).
Mishra et al.[7] in their case control study of 71 subjects 
with type 2 DM found that asymptomatic diabetic 
patients have reduced LV systolic and diastolic function 
as compared with healthy subjects. LV systolic and 
diastolic abnormalities are correlated with the duration 
of diabetes and with diabetic microangiopathies, like 
retinopathy and neuropathy. These results are comparable 
with present study, where 54.33% of type -2 DM 
population had diastolic dysfunction and the DM was 
correlated to advancing age, increasing duration of DM, 
postural hypotension, retinopathy, high obesity indices,   
HbA1c >7.5% and dyslipidemia.
From et al.[2] in their study of 484 subjects between 
1996 to 2007 year found that a duration of diabetes   
≥ 4 years was independently associated with LV diastolic 
dysfunction (E/e’ >15) with odds ratio 1.91. Doppler 
imaging velocity of the medial mitral annulus during 
passive filling (E/e’) ratio in diabetic patients is associated 
with the subsequent development of HF and increased 
mortality. Similarly in our study, duration of diabetes 11-
15 yrs had more prevalence of diastolic dysfunction as 
compared to the 6-10 year group (‘P’ < 0.02). Sohail et 
al.[13] in their study of 212 diabetic population found that 
30.76% patients with type-2 DM had diastolic dysfunction. 
The LV diastolic dysfunction is much more prevalent in 
patients with type-2 diabetes mellitus and LV diastolic 
dysfunction is an early marker of diabetic cardiomyopathy. 
In our study, prevalence of type 2 DM was 54.33%. Exiara  
et al.[14] in their study of 114 subjects stated that the 
prevalence of LV diastolic dysfunction in normotensive, 
asymptomatic and well-controlled DM type 2 patients is 
high, and increases with age. A total of 63.2% patients 
had diastolic dysfunction in their study compared to our   
prevalence of 54.33%. Diamant et al.[15] stated that early 
(E) acceleration peak, deceleration peak, peak filling rate, 
and E/A ratio, and all other indices of diastolic function, 
were significantly decreased in patients with recently 
diagnosed, well-controlled and uncomplicated type 2 
diabetes compared with the controls (‘P’ < 0.02). These 
findings are similar to our results. Bonito, et al.[16] stated 
that, an impairment of LV diastolic function occurs 
early in the natural history of type-2 DM, and is related 
to clinical evidence of microangiopathic complications. 
Aaron et al.[17] in 1,760 diabetic patients found that, 411 
(23%) patients had diastolic dysfunction and diabetic 
patients with diastolic dysfunction had a significantly 
higher mortality rate compared with those without 
diastolic dysfunction. An increase in the TDI velocity 
of the medial mitral annulus during passive filling (E/e’) 
ratio in diabetic patients is associated with the subsequent 
development of HF. These findings are comparable with 
our study.
Boyer et al.[18] stated that the prevalence of LV diastolic 
dysfunction in asymptomatic, normotensive patients with 
type 2 diabetes disease is high. Diastolic dysfunction 
was found in 75% subjects. They also found that, TDI 
detected diastolic dysfunction more often than any other 
echocardiographic parameter. In our study, prevalence 
of diastolic dysfunction was 54.33%. Poulsen  et al.[19] 
in their prospective observational study of 305 patients 
with type 2 DM found that, abnormal LV filling is 
closely associated with abnormal myocardial perfusion on 
myocardial perfusion scintigraphy. Takeda et al.[20] in their 
population of 544 consecutive Japanese DM patients with 
ejection fraction ≥ 50%, found that diastolic dysfunction 
(impaired relaxation) plays a crucial role in the induction 
of HF with normal systolic function in DM patients, 
regardless of the severity of DM and renal dysfunction. 
These findings are partially comparable with our study 
where diastolic dysfunction was more prevalent with 
HbA1c > 7.5. 
Poanta et al.[21] in their study of 58 subjects found that, 
cardiac autonomic neuropathy was associated with LV 
diastolic dysfunction in patients with type 2 DM, but 
without clinical manifestation of the heart disease. Similarly 
Poirier et al.[22] stated that, diastolic dysfunction and CAN 
(cardiac autonomic neuropathy) are associated in patients 
with otherwise uncomplicated well-controlled type 2 
DM. Hameedullah et al.[23] in their study population of 
60 patients with type 2 DM found that there was strong 
correlation between HbA1c level and diastolic indices   
(‘P’ < 0.05). Diastolic dysfunction was more frequent 
in poorly controlled diabetic patients, and its severity 
is correlated with glycaemic control. Similarly in our 
study, HbA1c > 7.5 % had higher prevalence of diastolic 
dysfunction compared to HbA1c < 7.5%. C.M. Schannwell 
et al.[24] in their study population of 87 subjects concluded 
that even young subjects with diabetes mellitus suffer 
from a diastolic dysfunction, while systolic ventricular 
function is normal. From the above discussion and 
comparison of present study findings with various studies, 
we found that there was high prevalence of diastolic 
dysfunction in subjects with asymptomatic type 2 DM, and 
it was correlated with age, duration of diabetes, HbA1c, 
dyslipidemia, autonomic neuropathy, retinopathy and 
various obesity indices.221 Journal of Cardiovascular Disease Research Vol. 2 / No 4
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Our study demonstrates that the incidence of pre-clinical 
diastolic dysfunction is high in type 2 DM subjects. 
Furthermore, we found that there is a direct correlation 
between the duration of DM and diastolic dysfunction; 
and, that significant diastolic dysfunction occurs > 5 
years after the onset of DM independent of coronary 
disease or hypertension. Therefore, future studies should 
be conducted to test the hypothesis that screening 
and aggressive management of diabetic patients with   
pre-clinical diastolic dysfunction may delay the progression 
to heart failure.
Study limitations 
The study was conducted on Indian general population. 
Thus, these findings need to be examined in different racial 
and ethnic groups. Homeostatic model assessment (HOMA) 
index for investigating fasting insulin concentration is not 
calculated in the present study due to resources limitations. 
HOMA index is considered as an independent factor for 
diastolic dysfunction.
CONCLUSIONS
Overall prevalence of diastolic dysfunction was 54.33% 
in asymptomatic type 2 DM subjects in the present study. 
Asymptomatic type 2 DM had significantly high prevalence 
of diastolic dysfunction as compared to healthy subjects. 
LV diastolic abnormalities were correlated with the duration 
of diabetes and with diabetic microangiopathies, like 
retinopathy and autonomic neuropathy. In the present study, 
DM was the strongest independent factor for LV diastolic 
dysfunction. This study confirms that asymptomatic 
diastolic dysfunction is more prevalent in subjects with type 
2-DM. There was a significant correlation of LV diastolic 
dysfunction with the duration of diabetes, glycatedHbA1c 
levels, obesity indices (WC and WHR), retinopathy, 
autonomic neuropathy and hypertriglyceridemia, as 
determined by multivariate analysis. We conclude that 
early diagnosis and institution of treatment for diastolic 
dysfunction in the form of ACE inhibitors, angiotensin 
II receptor blockers, aldosterone antagonists, diuretics etc. 
depending on clinical scenario, will reduce the morbidity 
and improve the outcome of diastolic HF. In order to 
improve the current poor prognosis in subjects with DM, 
the treatment of diastolic HF must be optimised. Subjects 
with DM type 2 should be screened for sub clinical diastolic 
dysfunction by echocardiography.
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